sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Saccharomyces cerevisiae

Medicine · alpha-Adrenergic Agonist

Saccharomyces cerevisiae

NON-STANDARDIZED ALLERGENIC EXTRACTS are indicated for: Skin test diagnosis of individuals with a clinical history of allergy to the specific corresponding allergens.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
NON-STANDARDIZED ALLERGENIC EXTRACTS are indicated for: Skin test diagnosis of individuals with a clinical history of allergy to the specific corresponding allergens.
Do not take if
  • Severe, unstable or uncontrolled asthma.
  • History of any severe systemic reaction to the allergen extract when administered for diagnosis or treatment.
  • Medical conditions that reduce the ability to survive anaphylaxis.

What it is used for

NON-STANDARDIZED ALLERGENIC EXTRACTS are indicated for:

  • Skin test diagnosis of individuals with a clinical history of allergy to the specific corresponding allergens.

NON-STANDARDIZED ALLERGENIC EXTRACTS are indicated for:

  • Immunotherapy for the reduction of allergen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for allergen specific IgE antibodies for the specific corresponding allergens.

Side effects, and when to stop

Common adverse reactions reported for non-standardized allergenic extracts are:

  • Local reactions occurring in 26 to 82% of all patients who receive subcutaneous immunotherapy, at the injection site (e.g., erythema, swelling, pruritus, tenderness and pain). 2
  • Systemic adverse reactions, occurring in ≤ 7% of patients who receive subcutaneous immunotherapy (e.g., generalized skin erythema, urticaria, pruritus, angioedema, rhinitis, wheezing, laryngeal edema, hypotension, and shock). 3 Systemic reactions may be fatal. 2

No clinical trials of non-standardized allergenic extracts have been conducted.

Published studies of non-standardized allergenic extracts report systemic reactions occurring in fewer than 1% in patients receiving conventional immunotherapy and greater than 36% in patients receiving rush immunotherapy. Most systemic reactions occurred within 30 minutes of injection. However, systemic reactions have been reported to occur up to 2 hours after the final injection with rush schedules. Some reactions have occurred up to 6 hours after skin tests or immunotherapy. 2, 3

Who should not take it

Non-standardized allergenic extracts are contraindicated in individuals with the following conditions:

  • Severe, unstable or uncontrolled asthma.
  • History of any severe systemic reaction to the allergen extract when administered for diagnosis or treatment.
  • Medical conditions that reduce the ability to survive anaphylaxis.

2 dosage and administration

For percutaneous, intradermal, or subcutaneous administration only. Do not inject intravenously.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Saccharomyces cerevisiae; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/saccharomyces-cerevisiae

APA 7th

sofidex. (2026, August 3). Saccharomyces cerevisiae. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/saccharomyces-cerevisiae

AMA 11th

Saccharomyces cerevisiae. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/saccharomyces-cerevisiae

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.